Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
bsmmu.edu.bdTotal trials
126
Active
19
Phase 3
13
Total enrollment
13,510
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 14 of 14 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| vonoprazan-based triple therapy | — | — | — | — | — | 1 | |
| Esomeprazole-based triple therapy | — | — | — | — | — | 1 | |
| Metformin Hydrochloride | — | — | — | — | — | 1 | |
| Metformin with Semaglutide | — | — | — | — | — | 1 | |
| tab baricitinib 4 mg daily | — | — | — | — | — | 1 | |
| tab methotrexate 25 mg weekly with folic acid 5 mg weekly | — | — | — | — | — | 1 | |
| Metformin | — | — | — | — | — | 1 | |
| To see the efficacy of Upadacitinib, Methotrexate versus Tofacitinib, Methotrexate in moderate to severe Rheumatoid arthritis | — | — | — | — | — | 1 | |
| Methotrexate | — | — | — | — | 2 | ||
| Nigella Sativa capsule 500mg | — | — | — | — | — | 1 | |
| sulfonylurease with metformin, DPP4 inhibitors with Metformin | — | — | — | — | — | 1 | |
| Omega 3 fatty acids | — | — | — | — | — | 1 | |
| Omega -3 fatty acids | — | — | — | — | — | 1 | |
| PRP | — | — | — | — | — | 1 |
Next readouts
- 2024-08-30
- 2024-08-31
- 2025-05
- 2025-06-30
- 2025-10-30
- 2025-10-31
- 2025-11-30
- 2026-04
- 2026-07-01
- 2026-08-14
Top conditions
- Chronic Arsenic Poisoning7
- Keratotic Nodular Size6
- Arsenical Keratosis4
- MDD3
- Parkinson Disease3
- OCD3
- Rheumatoid Arthritis3
- Covid193
Frequently asked questions about Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- How many clinical trials does Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh have on ClinicalTrials.gov?
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh is listed as the lead sponsor on 126 clinical trials in ClinicalTrials.gov, 19 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh's trials are in Phase 3?
- 13 of Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh's trials are in Phase 3, spread across 14 active drug programs.
- What therapeutic areas does Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh focus on?
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh's most-studied conditions on ClinicalTrials.gov are Chronic Arsenic Poisoning, Keratotic Nodular Size, Arsenical Keratosis, MDD, Parkinson Disease.
- When are Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh's next clinical trial readouts?
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh has 10 upcoming primary-completion readouts tracked here; the soonest is “Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.”, expected around 2024-08-30.